Skip to Content

Veeva Systems Inc Class A VEEV

Morningstar Rating
$222.86 +0.87 (0.39%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Veeva Earnings: Caps Off the Year on Strong Footing With All Gears Turning in Right Direction

Wide-moat Veeva Systems reported fourth-quarter earnings that came in slightly ahead of our expectations. Total sales of $630 million were up 11.9% year over year as both the subscription and services businesses outperformed management’s expected numbers. After adjusting our near-term assumptions and baking in the time value of money, we slightly raise up our fair value estimate to $270 per share from $267.

Price vs Fair Value

VEEV is trading within a range we consider fairly valued.
Price
$222.01
Fair Value
$135.00
Uncertainty
High
1-Star Price
$577.20
5-Star Price
$418.00
Economic Moat
Zcns
Capital Allocation
Tdjtjrylm

Bulls Say, Bears Say

Bulls

Veeva Vault continues to implement new products to its suite, which makes the offering even more attractive.

Bears

Moving its CRM from Salesforce’s platform to its Vault Platform could raise concerns for customers and lower its retention rate.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VEEV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$221.99
Day Range
$221.83223.69
52-Week Range
$160.25230.60
Bid/Ask
$222.81 / $223.18
Market Cap
$35.72 Bil
Volume/Avg
504 / 1.3 Mil

Key Statistics

Price/Earnings (Normalized)
48.16
Price/Sales
15.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Mid Growth
Total Number of Employees
6,744

Competitors

Valuation

Metric
VEEV
CRM
ORCL
Price/Earnings (Normalized)
48.1640.3620.99
Price/Book Value
7.705.1480.90
Price/Sales
15.368.956.18
Price/Cash Flow
42.6723.8317.32
Price/Earnings
VEEV
CRM
ORCL

Financial Strength

Metric
VEEV
CRM
ORCL
Quick Ratio
5.520.860.63
Current Ratio
5.641.040.79
Interest Coverage
13.093.75
Quick Ratio
VEEV
CRM
ORCL

Profitability

Metric
VEEV
CRM
ORCL
Return on Assets (Normalized)
15.35%8.01%11.39%
Return on Equity (Normalized)
19.15%12.86%11,805.30%
Return on Invested Capital (Normalized)
18.86%10.76%20.08%
Return on Assets
VEEV
CRM
ORCL
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockRmxhwz$42.2 Bil
MTHRF
M3 IncFnqdnv$9.8 Bil
MTHRY
M3 Inc ADRDnhxwzr$9.8 Bil
PMCUF
Pro Medicus LtdPbqgnfy$7.0 Bil
HQY
HealthEquity IncYzdjz$7.0 Bil
RCM
R1 RCM IncXxl$5.9 Bil
TXG
10x Genomics Inc Ordinary Shares - Class APphd$5.4 Bil
DOCS
Doximity Inc Class AZbkkf$5.2 Bil
EVH
Evolent Health Inc Class ADftldmt$3.9 Bil

Sponsor Center